US2003199A
(en)
|
1930-05-31 |
1935-05-28 |
Johnson Frank James |
Automatic coal stoker
|
US2003149A
(en)
|
1931-05-22 |
1935-05-28 |
Autographic Register Co |
Manifolding
|
US2003065A
(en)
|
1931-06-20 |
1935-05-28 |
John R Ditmars |
Composition for coating sheets, fibrous stocks, and the like
|
US2004102A
(en)
|
1932-02-24 |
1935-06-11 |
Daniel A Dickey |
Hollow steel propeller construction
|
US2004138A
(en)
|
1932-11-30 |
1935-06-11 |
Byers A M Co |
Method of making wrought iron pipe
|
US2002165A
(en)
|
1933-07-08 |
1935-05-21 |
Charles A Winslow |
Air cleaner
|
US2003187A
(en)
|
1933-10-02 |
1935-05-28 |
Frederick H Shaw |
Automobile radio device
|
US2003166A
(en)
|
1933-10-26 |
1935-05-28 |
Zancan Ottavio |
Front drive for motor cars
|
US2001051A
(en)
|
1933-12-01 |
1935-05-14 |
Angelina Mariani |
Tamperproof meter box with cutout control and fuse drawer for electric meters
|
US2004092A
(en)
|
1933-12-15 |
1935-06-11 |
John L Chaney |
Device for indicating the temperature of liquids
|
US2003060A
(en)
|
1934-04-02 |
1935-05-28 |
Ernest L Heckert |
Thermostatic controlling device
|
US2667486A
(en)
|
1951-05-24 |
1954-01-26 |
Research Corp |
2,4-diamino pteridine and derivatives
|
IL44058A
(en)
|
1973-02-02 |
1978-10-31 |
Ciba Geigy Ag |
3amino-1,2,4-benzotriazine 1,4-di-noxide derivatives, their preparation and compositions for the control of microorganisms containing them
|
AU535258B2
(en)
|
1979-08-31 |
1984-03-08 |
Ici Australia Limited |
Benzotriazines
|
DE3205638A1
(de)
|
1982-02-17 |
1983-08-25 |
Hoechst Ag, 6230 Frankfurt |
Trisubstituierte pyrimidin-5-carbonsaeuren und deren derivate, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel
|
US4490289A
(en)
|
1982-09-16 |
1984-12-25 |
Hoffmann-La Roche Inc. |
Homogeneous human interleukin 2
|
US5624925A
(en)
|
1986-09-25 |
1997-04-29 |
Sri International |
1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents
|
JP2598100B2
(ja)
|
1988-08-31 |
1997-04-09 |
キヤノン株式会社 |
電子写真感光体
|
US5214059A
(en)
|
1989-07-03 |
1993-05-25 |
Hoechst-Roussel Pharmaceuticals Incorporated |
2-(aminoaryl) indoles and indolines as topical antiinflammatory agents for the treatment of skin disorders
|
US5665543A
(en)
|
1989-07-18 |
1997-09-09 |
Oncogene Science, Inc. |
Method of discovering chemicals capable of functioning as gene expression modulators
|
US5776502A
(en)
|
1989-07-18 |
1998-07-07 |
Oncogene Science, Inc. |
Methods of transcriptionally modulating gene expression
|
US5041430A
(en)
*
|
1989-09-18 |
1991-08-20 |
Du Pont Mereck Pharmaceutical Company |
Oral anticoagulant/platelet inhibitor low dose formulation
|
JPH03127790A
(ja)
|
1989-10-11 |
1991-05-30 |
Morishita Pharmaceut Co Ltd |
N―(1h―テトラゾール―5―イル)―2―アニリノ―5―ピリミジンカルボキシアミド類及びその合成中間体
|
GB9003553D0
(en)
|
1990-02-16 |
1990-04-11 |
Ici Plc |
Herbicidal compositions
|
JP2839106B2
(ja)
|
1990-02-19 |
1998-12-16 |
キヤノン株式会社 |
電子写真感光体
|
GB9012592D0
(en)
|
1990-06-06 |
1990-07-25 |
Smithkline Beecham Intercredit |
Compounds
|
FR2665159B1
(fr)
|
1990-07-24 |
1992-11-13 |
Rhone Poulenc Sante |
Nouveaux derives de la pyridine et de la quinoleine, leur preparation et les compositions pharmaceutiques qui les contiennent.
|
MY107955A
(en)
|
1990-07-27 |
1996-07-15 |
Ici Plc |
Fungicides.
|
GB9016800D0
(en)
|
1990-07-31 |
1990-09-12 |
Shell Int Research |
Tetrahydropyrimidine derivatives
|
DE4025891A1
(de)
|
1990-08-16 |
1992-02-20 |
Bayer Ag |
Pyrimidyl-substituierte acrylsaeureester
|
JPH05345780A
(ja)
|
1991-12-24 |
1993-12-27 |
Kumiai Chem Ind Co Ltd |
ピリミジンまたはトリアジン誘導体及び除草剤
|
HUT63941A
(en)
|
1992-05-15 |
1993-11-29 |
Hoechst Ag |
Process for producing 4-alkyl-substituted pyrimidine-5-carboxanilide derivatives, and fungicidal compositions comprising same
|
US5438130A
(en)
|
1993-01-15 |
1995-08-01 |
Cambridge Neuroscience, Inc. |
Fucosylated guanosine disulfates as excitatory amino acid antagonists
|
JPH0741461A
(ja)
|
1993-05-27 |
1995-02-10 |
Eisai Co Ltd |
スルホン酸エステル誘導体
|
JPH0782183A
(ja)
|
1993-09-09 |
1995-03-28 |
Canon Inc |
液晶中間体化合物、液晶性化合物、高分子液晶化合物、高分子液晶共重合体化合物、それらの組成物、液晶素子および記録装置
|
DE4338704A1
(de)
|
1993-11-12 |
1995-05-18 |
Hoechst Ag |
Stabilisierte Oligonucleotide und deren Verwendung
|
US5530000A
(en)
|
1993-12-22 |
1996-06-25 |
Ortho Pharmaceutical Corporation |
Substituted pyrimidinylaminothiazole derivatives useful as platelet aggreggation inhibitors
|
GB9506466D0
(en)
|
1994-08-26 |
1995-05-17 |
Prolifix Ltd |
Cell cycle regulated repressor and dna element
|
US5597826A
(en)
|
1994-09-14 |
1997-01-28 |
Pfizer Inc. |
Compositions containing sertraline and a 5-HT1D receptor agonist or antagonist
|
DE19502912A1
(de)
|
1995-01-31 |
1996-08-01 |
Hoechst Ag |
G-Cap Stabilisierte Oligonucleotide
|
US6326487B1
(en)
|
1995-06-05 |
2001-12-04 |
Aventis Pharma Deutschland Gmbh |
3 modified oligonucleotide derivatives
|
JPH11512399A
(ja)
|
1995-09-01 |
1999-10-26 |
シグナル ファーマシューティカルズ,インコーポレイテッド |
ピリミジンカルボキサミドおよび関連化合物ならびに炎症状態を処置するための方法
|
GB9523675D0
(en)
|
1995-11-20 |
1996-01-24 |
Celltech Therapeutics Ltd |
Chemical compounds
|
AU1353897A
(en)
|
1995-12-29 |
1997-07-28 |
Smithkline Beecham Corporation |
Vitronectin receptor antagonists
|
JPH09274290A
(ja)
|
1996-02-07 |
1997-10-21 |
Fuji Photo Film Co Ltd |
ハロゲン化銀写真感光材料用の現像液および処理方法
|
DK0939632T3
(da)
|
1996-02-23 |
2006-01-30 |
Lilly Co Eli |
Non-peptidyl vasopressin V1a antagonister
|
DE59707681D1
(de)
|
1996-10-28 |
2002-08-14 |
Rolic Ag Zug |
Vernetzbare, photoaktive Silanderivate
|
EP0968284B1
(en)
|
1996-11-20 |
2006-12-13 |
Introgen Therapeutics, Inc. |
An improved method for the production and purification of adenoviral vectors
|
JP3734903B2
(ja)
|
1996-11-21 |
2006-01-11 |
富士写真フイルム株式会社 |
現像処理方法
|
JPH10153838A
(ja)
|
1996-11-22 |
1998-06-09 |
Fuji Photo Film Co Ltd |
ハロゲン化銀写真感光材料の処理方法
|
JP3720931B2
(ja)
|
1996-11-26 |
2005-11-30 |
富士写真フイルム株式会社 |
ハロゲン化銀写真感光材料の処理方法
|
US5935383A
(en)
|
1996-12-04 |
1999-08-10 |
Kimberly-Clark Worldwide, Inc. |
Method for improved wet strength paper
|
ID22290A
(id)
|
1996-12-04 |
1999-09-30 |
Kimberly Clark Co |
Metoda untuk pembuatan kertas yang kuat pada saat basah
|
AU6645998A
(en)
|
1996-12-23 |
1998-07-17 |
Du Pont Pharmaceuticals Company |
Oxygen or sulfur containing heteroaromatics as factor xa inhibitors
|
JPH10207019A
(ja)
|
1997-01-22 |
1998-08-07 |
Fuji Photo Film Co Ltd |
ハロゲン化銀写真感光材料の処理方法
|
JPH10213820A
(ja)
|
1997-01-31 |
1998-08-11 |
Canon Inc |
液晶素子及び液晶装置
|
DE59807348D1
(de)
|
1997-02-05 |
2003-04-10 |
Rolic Ag Zug |
Photovernetzbare Silanderivate
|
GB9705361D0
(en)
|
1997-03-14 |
1997-04-30 |
Celltech Therapeutics Ltd |
Chemical compounds
|
JPH10260512A
(ja)
|
1997-03-19 |
1998-09-29 |
Fuji Photo Film Co Ltd |
ハロゲン化銀感光材料の処理方法
|
JPH10310583A
(ja)
|
1997-05-09 |
1998-11-24 |
Mitsubishi Chem Corp |
ピリドンアゾ系化合物、感熱転写用色素およびそれを使用した感熱転写材料
|
US6070126A
(en)
|
1997-06-13 |
2000-05-30 |
William J. Kokolus |
Immunobiologically-active linear peptides and method of identification
|
TW436485B
(en)
|
1997-08-01 |
2001-05-28 |
American Cyanamid Co |
Substituted quinazoline derivatives
|
US6635626B1
(en)
|
1997-08-25 |
2003-10-21 |
Bristol-Myers Squibb Co. |
Imidazoquinoxaline protein tyrosine kinase inhibitors
|
US6022884A
(en)
|
1997-11-07 |
2000-02-08 |
Amgen Inc. |
Substituted pyridine compounds and methods of use
|
EP1054004B1
(en)
|
1997-12-15 |
2008-07-16 |
Astellas Pharma Inc. |
Novel pyrimidine-5-carboxamide derivatives
|
EP1042299A1
(en)
|
1997-12-22 |
2000-10-11 |
Du Pont Pharmaceuticals Company |
Nitrogen containing heteroaromatics with ortho-substituted p1's as factor xa inhibitors
|
ATE245641T1
(de)
|
1998-02-17 |
2003-08-15 |
Tularik Inc |
Antivirale pyrimidinderivate
|
KR100643419B1
(ko)
|
1998-03-27 |
2006-11-10 |
얀센 파마슈티카 엔.브이. |
Hiv를 억제하는 피리미딘 유도체
|
ATE232521T1
(de)
|
1998-03-27 |
2003-02-15 |
Janssen Pharmaceutica Nv |
Hiv hemmende pyrimidin derivate
|
US6685938B1
(en)
|
1998-05-29 |
2004-02-03 |
The Scripps Research Institute |
Methods and compositions useful for modulation of angiogenesis and vascular permeability using SRC or Yes tyrosine kinases
|
DE19830181C1
(de)
|
1998-07-06 |
1999-09-30 |
Inter Control Koehler Hermann |
Mehrpolige elektrische Steckverbindung
|
US6136971A
(en)
|
1998-07-17 |
2000-10-24 |
Roche Colorado Corporation |
Preparation of sulfonamides
|
US6378526B1
(en)
|
1998-08-03 |
2002-04-30 |
Insite Vision, Incorporated |
Methods of ophthalmic administration
|
US6288082B1
(en)
|
1998-09-29 |
2001-09-11 |
American Cyanamid Company |
Substituted 3-cyanoquinolines
|
AU763669B2
(en)
|
1998-09-29 |
2003-07-31 |
Wyeth Holdings Corporation |
Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
|
BR9914164A
(pt)
|
1998-09-29 |
2001-06-26 |
American Cyanamid Co |
Composto, método para o tratamento, inibição do crescimento de, ou erradiacação de um neoplasma, e de doença de rim policìstico, em um mamìfero em necessidade do mesmo, composição farmacêutica, e, processo para preparar um composto
|
US6297258B1
(en)
|
1998-09-29 |
2001-10-02 |
American Cyanamid Company |
Substituted 3-cyanoquinolines
|
CA2320730A1
(en)
|
1998-12-23 |
2000-07-06 |
Renhua Li |
Thrombin or factor xa inhibitors
|
GB9828511D0
(en)
|
1998-12-24 |
1999-02-17 |
Zeneca Ltd |
Chemical compounds
|
WO2000046203A2
(en)
|
1999-02-04 |
2000-08-10 |
Millennium Pharmaceuticals, Inc. |
G-protein coupled heptahelical receptor binding compounds and methods of use thereof
|
BR0009721A
(pt)
|
1999-04-15 |
2002-02-13 |
Bristol Myers Squibb Co |
Inibidores de tirosina quinase de proteìna cìclica
|
DE60009888T2
(de)
|
1999-04-21 |
2005-04-21 |
Wyeth Corp |
Substituierte 3-cyano-[1.7], [1.5] und [1.8]naphthyridininhibitoren von tyrosin kinasen
|
WO2000071536A1
(en)
|
1999-05-20 |
2000-11-30 |
E.I. Du Pont De Nemours And Company |
Heteroaryloxypyrimidine insecticides and acaricides
|
US6710221B1
(en)
|
1999-06-15 |
2004-03-23 |
Kimberly-Clark Worldwide, Inc. |
Absorbent articles incorporating color change graphics
|
CA2377771A1
(en)
|
1999-07-01 |
2001-01-11 |
Ajinomoto Co., Inc. |
Heterocyclic compounds and medical use thereof
|
WO2001007027A2
(en)
|
1999-07-22 |
2001-02-01 |
Vertex Pharmaceuticals Incorporated |
Pyrimidine derivatives for the treatment of viral diseases
|
AU763976B2
(en)
|
1999-07-23 |
2003-08-07 |
Shionogi & Co., Ltd. |
Th2 differentiation inhibitors
|
AU6016000A
(en)
|
1999-07-23 |
2001-02-13 |
Shionogi & Co., Ltd. |
Tricyclic compounds and drug compositions containing the same
|
KR20020018201A
(ko)
|
1999-08-12 |
2002-03-07 |
윌리암 에이취 캘넌, 에곤 이 버그 |
결장 폴립 및 결장직장암의 치료 또는 억제용엔에스에이아이디 및 이지에프알 키나제 억제제 함유 조성물
|
US6127382A
(en)
|
1999-08-16 |
2000-10-03 |
Allergan Sales, Inc. |
Amines substituted with a tetrahydroquinolinyl group an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
|
US6093838A
(en)
|
1999-08-16 |
2000-07-25 |
Allergan Sales, Inc. |
Amines substituted with a dihydro-benzofuranyl or with a dihydro-isobenzofuranyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
|
ATE309241T1
(de)
|
1999-09-10 |
2005-11-15 |
Merck & Co Inc |
Tyrosin kinase inhibitoren
|
GB9922171D0
(en)
|
1999-09-21 |
1999-11-17 |
Zeneca Ltd |
Chemical compounds
|
JP2001089412A
(ja)
|
1999-09-22 |
2001-04-03 |
Otsuka Pharmaceut Co Ltd |
ベンゼン誘導体またはその医薬的に許容される塩
|
US6506769B2
(en)
|
1999-10-06 |
2003-01-14 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Heterocyclic compounds useful as inhibitors of tyrosine kinases
|
EP1223170B1
(en)
|
1999-10-12 |
2005-12-28 |
Takeda Pharmaceutical Company Limited |
Pyrimidine-5-carboxamide compounds, process for producing the same and use thereof
|
WO2001032628A1
(en)
|
1999-11-03 |
2001-05-10 |
Bristol-Myers Squibb Pharma Company |
Cyano compounds as factor xa inhibitors
|
GB9929988D0
(en)
|
1999-12-17 |
2000-02-09 |
Celltech Therapeutics Ltd |
Chemical compounds
|
US6638929B2
(en)
|
1999-12-29 |
2003-10-28 |
Wyeth |
Tricyclic protein kinase inhibitors
|
AU2464601A
(en)
|
1999-12-29 |
2001-07-09 |
Wyeth |
Tricyclic protein kinase inhibitors
|
WO2001055116A2
(en)
|
2000-01-28 |
2001-08-02 |
Astrazeneca Ab |
Quinoline derivatives and their use as aurora 2 kinase inhibitors
|
US6153752A
(en)
|
2000-01-28 |
2000-11-28 |
Creanova, Inc. |
Process for preparing heterocycles
|
US20020165244A1
(en)
|
2000-01-31 |
2002-11-07 |
Yuhong Zhou |
Mucin synthesis inhibitors
|
CN1429222A
(zh)
|
2000-02-17 |
2003-07-09 |
安姆根有限公司 |
激酶抑制剂
|
WO2001060392A1
(en)
|
2000-02-18 |
2001-08-23 |
Yeda Research And Development Co., Ltd. At The Weizmann Institute Of Science |
Oral, nasal and pulmonary dosage formualtions of copolymer 1
|
BR0108611A
(pt)
|
2000-02-25 |
2003-05-06 |
Hoffmann La Roche |
Moduladores de receptor de adenosina
|
US6605615B2
(en)
|
2000-03-01 |
2003-08-12 |
Tularik Inc. |
Hydrazones and analogs as cholesterol lowering agents
|
GB0004887D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
GB0004888D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
GB0004890D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
EP1261607B1
(en)
|
2000-03-01 |
2008-11-12 |
Janssen Pharmaceutica N.V. |
2,4-disubstituted thiazolyl derivatives
|
JP2001247411A
(ja)
|
2000-03-09 |
2001-09-11 |
Tomono Agrica Co Ltd |
有害生物防除剤
|
HUP0300547A2
(hu)
|
2000-03-13 |
2003-07-28 |
American Cyanamid Co. |
Ciano-kinolin vegyületek alkalmazása vastagbél polipok kezelésére és gátlására alkalmas gyógyszerkészítmények előállítására
|
US6613917B1
(en)
|
2000-03-23 |
2003-09-02 |
Allergan, Inc. |
Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
|
AR028261A1
(es)
|
2000-03-28 |
2003-04-30 |
Wyeth Corp |
Inhibidores triciclicos de la proteina quinasa
|
US6608048B2
(en)
|
2000-03-28 |
2003-08-19 |
Wyeth Holdings |
Tricyclic protein kinase inhibitors
|
KR20030009416A
(ko)
|
2000-04-04 |
2003-01-29 |
시오노기세이야쿠가부시키가이샤 |
고지용성 약물을 함유하는 유성 조성물
|
WO2001076582A1
(fr)
|
2000-04-05 |
2001-10-18 |
Shionogi & Co., Ltd. |
Micro-emulsions huile dans eau contenant des composes tricycliques ou des preconcentres de ceux-ci
|
US6471968B1
(en)
|
2000-05-12 |
2002-10-29 |
Regents Of The University Of Michigan |
Multifunctional nanodevice platform
|
DE10024622A1
(de)
|
2000-05-18 |
2001-11-22 |
Piesteritz Stickstoff |
N-(2-Pyrimidinyl)(thio)phosphorsäuretriamide, Verfahren zu ihrer Herstellung und deren Verwendung als Mittel zur Regulierung bzw. Hemmung der enzymatischen Harnstoff-Hydrolyse
|
DE60114518T2
(de)
|
2000-07-06 |
2006-08-10 |
Fuji Photo Film Co. Ltd., Minamiashigara |
Flüssigkristallzusammensetzung, die Flüssigkristallmoleküle und Ausrichtungsmittel enthält
|
MXPA03001306A
(es)
|
2000-08-11 |
2003-10-15 |
Boehringer Ingelheim Pharma |
Compuestos heterociclicos utiles como inhibidores de las quinasas de tirosina.
|
CA2422371C
(en)
|
2000-09-15 |
2010-05-18 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
EP1578341A2
(en)
|
2000-10-11 |
2005-09-28 |
Tularik Inc. |
Modulation of ccr4 function
|
WO2002044166A1
(en)
|
2000-11-02 |
2002-06-06 |
Astrazeneca Ab |
Substituted quinolines as antitumor agents
|
JP2004517059A
(ja)
|
2000-11-02 |
2004-06-10 |
アストラゼネカ アクチボラグ |
抗腫瘍剤用の4−置換キノリン類
|
JP2004517074A
(ja)
|
2000-11-20 |
2004-06-10 |
ファルマシア・コーポレーション |
凝血カスケードを選択的に阻害するのに有用な置換された多環アリールおよびヘテロアリールピリジン類
|
US20070026433A1
(en)
*
|
2001-03-09 |
2007-02-01 |
Hildebrand William H |
Epitope testing using soluble HLA
|
WO2002053160A1
(en)
|
2000-12-29 |
2002-07-11 |
Alteon, Inc. |
Method for treating glaucoma ivb
|
WO2002053101A2
(en)
|
2000-12-29 |
2002-07-11 |
Alteon, Inc. |
Method for treating fibrotic diseases or other indications
|
JP2002221770A
(ja)
|
2001-01-24 |
2002-08-09 |
Fuji Photo Film Co Ltd |
ハロゲン化銀写真感光材料およびその処理方法
|
WO2002064096A2
(en)
|
2001-02-16 |
2002-08-22 |
Tularik Inc. |
Methods of using pyrimidine-based antiviral agents
|
EP1379520B2
(en)
|
2001-02-23 |
2014-04-09 |
Merck Sharp & Dohme Corp. |
N-substituted nonaryl-heterocyclic nmda/nr2b antagonists
|
JP2004525139A
(ja)
|
2001-03-23 |
2004-08-19 |
中外製薬株式会社 |
Flt−1リガンド、および血管形成により調節可能な疾患の治療におけるそれらの使用
|
WO2002083667A2
(en)
|
2001-04-13 |
2002-10-24 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
|
US20040157866A1
(en)
|
2001-04-30 |
2004-08-12 |
Hisashi Takasugi |
Amide compounds
|
MXPA03010269A
(es)
|
2001-05-11 |
2004-05-05 |
Vertex Pharma |
Derivados de 2,5-disubstituida piridina, pirimidina, piridazina y 1,2,4-triazina para usarse como inhibidores de p38.
|
WO2002094766A1
(fr)
|
2001-05-18 |
2002-11-28 |
Nihon Nohyaku Co., Ltd. |
Derive de phtalamide, insecticide agricole et horticole et son utilisation
|
WO2002096903A2
(fr)
|
2001-05-28 |
2002-12-05 |
Aventis Pharma S.A. |
Derives chimiques et leur application comme agent antitelomerase
|
PL367130A1
(en)
|
2001-05-29 |
2005-02-21 |
Schering Aktiengesellschaft |
Cdk inhibiting pyrimidines, production thereof and their use as medicaments
|
US7025987B2
(en)
|
2001-05-30 |
2006-04-11 |
The Scripps Research Institute |
Delivery system for nucleic acids
|
ATE339418T1
(de)
|
2001-06-01 |
2006-10-15 |
Vertex Pharma |
Thiazolverbindungen, die sich als inhibitoren von proteinkinasen eignen
|
DE60214198T2
(de)
|
2001-07-03 |
2007-08-09 |
Vertex Pharmaceuticals Inc., Cambridge |
Isoxazolyl-pyrimidines als inhibitoren von src- und lck-protein-kinasen
|
US6861529B2
(en)
|
2001-07-06 |
2005-03-01 |
Pfizer Inc |
Cycloalkypyrrole-3-carboxylic acid derivatives and heterocycloalkylpyrrole-3-carboxylic acid derivatives
|
JO3429B1
(ar)
|
2001-08-13 |
2019-10-20 |
Janssen Pharmaceutica Nv |
مشتقات برميدينات مثبطة فيروس الايدز
|
EP1429765A2
(en)
|
2001-09-14 |
2004-06-23 |
Methylgene, Inc. |
Inhibitors of histone deacetylase
|
WO2003030909A1
(en)
|
2001-09-25 |
2003-04-17 |
Bayer Pharmaceuticals Corporation |
2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer
|
DE10150615A1
(de)
|
2001-10-12 |
2003-04-30 |
Clariant Gmbh |
Verfahren zur metallorganischen Herstellung organischer Zwischenprodukte
|
DE10150610A1
(de)
|
2001-10-12 |
2003-04-30 |
Clariant Gmbh |
Verfahren zur metallorganischen Herstellung organischer Zwischenprodukte über Amidbasen
|
DE10150614A1
(de)
|
2001-10-12 |
2003-04-30 |
Clariant Gmbh |
Verfahren zur metallorganischen Herstellung organischer Zwischenprodukte über Halogen-Metall-Austauschreaktionen
|
EP1453516A2
(de)
|
2001-10-17 |
2004-09-08 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
5-substituierte 4-amino-2-phenylamino-pyrimdinderivate und ihre verwendung als beta-amyloid modulatoren
|
CA2463822A1
(en)
|
2001-11-01 |
2003-05-08 |
Janssen Pharmaceutica N.V. |
Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors)
|
WO2003037869A1
(en)
|
2001-11-01 |
2003-05-08 |
Janssen Pharmaceutica N.V. |
Amide derivatives as glycogen synthase kinase 3-beta inhibitors
|
US6821988B2
(en)
|
2001-11-27 |
2004-11-23 |
Wyeth Holdings Corporation |
3-cyanoquinolines as inhibitors of EGF-R and HER2 kinases
|
JP2005510564A
(ja)
|
2001-11-28 |
2005-04-21 |
藤沢薬品工業株式会社 |
アポリポタンパク質b阻害剤としての複素環式アミド化合物
|
US20030187026A1
(en)
|
2001-12-13 |
2003-10-02 |
Qun Li |
Kinase inhibitors
|
US7910586B2
(en)
|
2002-01-04 |
2011-03-22 |
The Rockefeller University |
Compositions and methods for prevention and treatment of amyloid-β peptide-related disorders
|
US20030166932A1
(en)
|
2002-01-04 |
2003-09-04 |
Beard Richard L. |
Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
EP1472213B1
(en)
|
2002-02-05 |
2010-06-09 |
Wyeth a Corporation of the State of Delaware |
Process for the synthesis of n-acyl-2-amino-4-alkoxy-5-nitrobenzoic acids
|
WO2003066601A1
(en)
|
2002-02-08 |
2003-08-14 |
Smithkline Beecham Corporation |
Pyrimidine compounds
|
JP2005524668A
(ja)
|
2002-03-01 |
2005-08-18 |
スミスクライン ビーチャム コーポレーション |
ジアミノピリミジン類及びそれらの血管新生阻害薬としての使用
|
GB0206215D0
(en)
|
2002-03-15 |
2002-05-01 |
Novartis Ag |
Organic compounds
|
AU2003231231A1
(en)
|
2002-05-06 |
2003-11-11 |
Bayer Pharmaceuticals Corporation |
Pyridinyl amino pyrimidine derivatives useful for treating hyper-proliferative disorders
|
AR037647A1
(es)
|
2002-05-29 |
2004-12-01 |
Novartis Ag |
Derivados de diarilurea utiles para el tratamiento de enfermedades dependientes de la cinasa de proteina
|
MY141867A
(en)
|
2002-06-20 |
2010-07-16 |
Vertex Pharma |
Substituted pyrimidines useful as protein kinase inhibitors
|
MXPA04011849A
(es)
|
2002-07-02 |
2005-03-31 |
Kimberly Clark Co |
Composiciones adhesivas elastomericas y laminados.
|
WO2004005283A1
(en)
|
2002-07-09 |
2004-01-15 |
Vertex Pharmaceuticals Incorporated |
Imidazoles, oxazoles and thiazoles with protein kinase inhibiting activities
|
ES2445208T3
(es)
|
2002-07-29 |
2014-02-28 |
Rigel Pharmaceuticals, Inc. |
Compuestos de 2,4-pirimidindiamina para uso en métodos para tratar o prevenir enfermedades autoinmunitarias
|
ES2294344T3
(es)
|
2002-08-02 |
2008-04-01 |
Ab Science |
2-(3-aminoaril)amino-4-aril-tiazoles y su utilizacion como inhibidores de c-kit.
|
PL375447A1
(en)
|
2002-08-14 |
2005-11-28 |
Vertex Pharmaceuticals Incorporated |
Protein kinase inhibitors and uses thereof
|
UY27939A1
(es)
|
2002-08-21 |
2004-03-31 |
Glaxo Group Ltd |
Compuestos
|
DE10240262A1
(de)
|
2002-08-31 |
2004-03-11 |
Clariant Gmbh |
Verfahren zur metallorganischen Herstellung organischer Zwischenprodukte über Aryllithium-Basen
|
DE10240261A1
(de)
|
2002-08-31 |
2004-03-11 |
Clariant Gmbh |
Verfahren zur metallorganischen Herstellung organischer Zwischenprodukte über Halogen-Metall-Austauschreaktionen
|
US20050282814A1
(en)
|
2002-10-03 |
2005-12-22 |
Targegen, Inc. |
Vasculostatic agents and methods of use thereof
|
US7208493B2
(en)
|
2002-10-03 |
2007-04-24 |
Targegen, Inc. |
Vasculostatic agents and methods of use thereof
|
US20060167021A1
(en)
|
2002-10-04 |
2006-07-27 |
Caritas St. Elizabeth's Medical Center Of Boston, Inc. |
Inhibition of src for treatment of reperfusion injury related to revascularization
|
WO2004037176A2
(en)
|
2002-10-21 |
2004-05-06 |
Bristol-Myers Squibb Company |
Quinazolinones and derivatives thereof as factor xa inhibitors
|
WO2004037814A1
(en)
|
2002-10-25 |
2004-05-06 |
Vertex Pharmaceuticals Incorporated |
Indazolinone compositions useful as kinase inhibitors
|
US7452911B2
(en)
|
2002-10-31 |
2008-11-18 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
|
DE10250708A1
(de)
|
2002-10-31 |
2004-05-19 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
|
CA2506773A1
(en)
|
2002-11-04 |
2004-05-21 |
Vertex Pharmaceuticals Incorporated |
Heteroaryl-pyramidine derivatives as jak inhibitors
|
US8034831B2
(en)
*
|
2002-11-06 |
2011-10-11 |
Celgene Corporation |
Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies
|
US20050101576A1
(en)
*
|
2003-11-06 |
2005-05-12 |
Novacea, Inc. |
Methods of using vitamin D compounds in the treatment of myelodysplastic syndromes
|
JP2006510661A
(ja)
|
2002-12-06 |
2006-03-30 |
ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー |
Pi3kの阻害剤としてのベンズオキサジン−3−オン類及びその誘導体
|
JP3837670B2
(ja)
|
2002-12-12 |
2006-10-25 |
富士通株式会社 |
データ中継装置、連想メモリデバイス、および連想メモリデバイス利用情報検索方法
|
AU2003299600A1
(en)
|
2002-12-20 |
2004-07-29 |
Pharmacia Corpration |
The r-isomer of beta amino acid compounds as integrin receptor antagonists derivatives
|
JP2006518333A
(ja)
|
2002-12-20 |
2006-08-10 |
ファルマシア・コーポレーション |
インテグリン受容体アンタゴニストとしてのヘテロアリールアルカン酸
|
UA80767C2
(en)
|
2002-12-20 |
2007-10-25 |
Pfizer Prod Inc |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
ATE412657T1
(de)
|
2002-12-24 |
2008-11-15 |
Astrazeneca Ab |
Therapeutische quinazolin-derivate
|
US7144911B2
(en)
|
2002-12-31 |
2006-12-05 |
Deciphera Pharmaceuticals Llc |
Anti-inflammatory medicaments
|
WO2004074266A1
(en)
|
2003-02-07 |
2004-09-02 |
Janssen Pharmaceutica N.V. |
Hiv inhibiting 1,2,4-triazines
|
CA2513527C
(en)
|
2003-02-07 |
2012-08-14 |
Janssen Pharmaceutica N.V. |
Pyrimidine derivatives for the prevention of hiv infection
|
CA2515544A1
(en)
|
2003-02-11 |
2004-08-26 |
Kemia Inc. |
Compounds for the treatment of viral infection
|
CL2004000303A1
(es)
|
2003-02-20 |
2005-04-08 |
Tibotec Pharm Ltd |
Compuestos derivados de pirimidinas y triazinas; proceso de preparacion; composicion farmaceutica; y su uso para inhibir la replicacion del vih.
|
GB0305929D0
(en)
|
2003-03-14 |
2003-04-23 |
Novartis Ag |
Organic compounds
|
CA2559670A1
(en)
|
2003-04-14 |
2004-10-28 |
Gabor Pragai |
Stable amlodipine maleate formulations
|
US20040265375A1
(en)
|
2003-04-16 |
2004-12-30 |
Platteeuw Johannes J. |
Orally disintegrating tablets
|
ES2634840T5
(es)
|
2003-04-24 |
2022-12-22 |
Coopervision Int Ltd |
Lentes de contacto de hidrogel y sistemas de envase y procedimientos de producción de los mismos
|
KR101201603B1
(ko)
|
2003-07-30 |
2012-11-14 |
리겔 파마슈티칼스, 인크. |
자가면역 질환의 치료 또는 예방에 사용하기 위한2,4-피리미딘디아민 화합물
|
MY147449A
(en)
|
2003-08-15 |
2012-12-14 |
Novartis Ag |
2, 4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
|
GB0321710D0
(en)
|
2003-09-16 |
2003-10-15 |
Novartis Ag |
Organic compounds
|
JP2007505858A
(ja)
|
2003-09-18 |
2007-03-15 |
ノバルティス アクチエンゲゼルシャフト |
増殖性障害の処置に有用な2,4−ジ(フェニルアミノ)ピリミジン
|
CA2567574C
(en)
|
2004-04-08 |
2013-01-08 |
Targegen, Inc. |
Benzotriazine inhibitors of kinases
|
NZ553492A
(en)
|
2004-08-25 |
2010-11-26 |
Targegen Inc |
Triazole derivatives and methods of use
|
US7210697B2
(en)
|
2004-12-16 |
2007-05-01 |
Tricam International, Inc. |
Convertible handle
|
JP5208516B2
(ja)
|
2004-12-30 |
2013-06-12 |
エグゼリクシス, インコーポレイテッド |
キナーゼモジュレーターとしてのピリミジン誘導体および使用方法
|
GT200600008A
(es)
*
|
2005-01-18 |
2006-08-09 |
|
Formulacion de compresion directa y proceso
|
GB0501999D0
(en)
|
2005-02-01 |
2005-03-09 |
Sentinel Oncology Ltd |
Pharmaceutical compounds
|
US20060247250A1
(en)
|
2005-03-16 |
2006-11-02 |
Targegen, Inc. |
Pyrimidine inhibitors of kinases
|
WO2006128129A2
(en)
|
2005-05-26 |
2006-11-30 |
Synta Pharmaceuticals Corp. |
Method for treating cancer
|
US20070032493A1
(en)
|
2005-05-26 |
2007-02-08 |
Synta Pharmaceuticals Corp. |
Method for treating B cell regulated autoimmune disorders
|
EP1893216A4
(en)
|
2005-06-08 |
2012-08-08 |
Targegen Inc |
METHOD AND COMPOSITIONS FOR THE TREATMENT OF EYE DISEASES
|
US7491732B2
(en)
|
2005-06-08 |
2009-02-17 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the JAK pathway
|
WO2006137658A1
(en)
|
2005-06-20 |
2006-12-28 |
Dongbu Hitek Co., Ltd. |
New substituted 1,3-thiazole derivatives or pharmaceutically acceptable salts thereof having immunosuppression and inflammation inhibitory acitivity, intermediate compounds or pharmaceutically acceptable salts thereof, a process for the preparation thereof, and pharmaceutical composition comprising the same
|
RS20070511A
(en)
|
2005-06-29 |
2009-01-22 |
Panacea Biotec Ltd., |
Modified release pharmaceutical compositions and processes thereof
|
WO2007008541A2
(en)
|
2005-07-08 |
2007-01-18 |
Kalypsys, Inc. |
Cellular cholesterol absorption modifiers
|
US7754717B2
(en)
|
2005-08-15 |
2010-07-13 |
Amgen Inc. |
Bis-aryl amide compounds and methods of use
|
US20070149506A1
(en)
|
2005-09-22 |
2007-06-28 |
Arvanitis Argyrios G |
Azepine inhibitors of Janus kinases
|
US20070072682A1
(en)
|
2005-09-29 |
2007-03-29 |
Crawford James T Iii |
Head to head electronic poker game assembly and method of operation
|
US8133900B2
(en)
*
|
2005-11-01 |
2012-03-13 |
Targegen, Inc. |
Use of bi-aryl meta-pyrimidine inhibitors of kinases
|
US8604042B2
(en)
|
2005-11-01 |
2013-12-10 |
Targegen, Inc. |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
PT1951684T
(pt)
|
2005-11-01 |
2016-10-13 |
Targegen Inc |
Inibidores de cinases de tipo biaril-meta-pirimidina
|
UA109411C2
(uk)
*
|
2005-11-01 |
2015-08-25 |
|
N-трет-бутил-3-(2-хлор-5-метилпіримідин-4-іламіно)бензолсульфонамід та його застосування в способі одержання сполуки
|
US20070149508A1
(en)
|
2005-11-02 |
2007-06-28 |
Targegen, Inc. |
Six membered heteroaromatic inhibitors targeting resistant kinase mutations
|
WO2007053776A1
(en)
|
2005-11-03 |
2007-05-10 |
Sgx Pharmaceuticals, Inc. |
Pyrimidinyl-thiophene kinase modulators
|
EP1954256A2
(en)
|
2005-11-09 |
2008-08-13 |
Torrent Pharmaceuticals Ltd |
Pharmaceutical composition comprising a compound having a catechol moiety and an alkalising agent
|
US8143255B2
(en)
|
2005-11-16 |
2012-03-27 |
S*Bio Pte Ltd. |
Heteroalkyl linked pyrimidine derivatives
|
TWI468162B
(zh)
|
2005-12-13 |
2015-01-11 |
英塞特公司 |
作為傑納斯激酶(JANUS KINASE)抑制劑之經雜芳基取代之吡咯并〔2,3-b〕吡啶及吡咯并〔2,3-b〕嘧啶
|
BRPI0706747A2
(pt)
*
|
2006-01-30 |
2011-04-05 |
Exelixis Inc |
4-aril-2-amino-pirimidinas ou 4-aril-2-aminoalquil-pirimidinas como moduladores jak-2 e composições farmacêuticas que os contenham
|
US8962643B2
(en)
|
2006-02-24 |
2015-02-24 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the JAK pathway
|
KR101784001B1
(ko)
*
|
2006-04-04 |
2017-10-23 |
케이지 액퀴지션 엘엘씨 |
항혈소판제와 산 억제제를 포함하는 경구 투여용 약학 조성물
|
US7691858B2
(en)
|
2006-04-25 |
2010-04-06 |
Targegen, Inc. |
Kinase inhibitors and methods of use thereof
|
JP2009537538A
(ja)
*
|
2006-05-15 |
2009-10-29 |
アカドイア プハルマセウチカルス インコーポレーテッド |
ピマバンセリン医薬製剤
|
WO2008008234A1
(en)
|
2006-07-07 |
2008-01-17 |
Targegen, Inc. |
2-amino-5-substituted pyrimidine inhibitors
|
BRPI0715418A2
(pt)
|
2006-07-21 |
2013-03-26 |
Novartis Ag |
compostos de 2,4-di(arilaminio)-pirimidina-5-carboxamida como inibidores de cinases jak
|
US20080021013A1
(en)
|
2006-07-21 |
2008-01-24 |
Cephalon, Inc. |
JAK inhibitors for treatment of myeloproliferative disorders
|
WO2008057233A2
(en)
*
|
2006-10-25 |
2008-05-15 |
The Regents Of The University Of California |
Models of erythropoiesis
|
SG10201509887UA
(en)
|
2007-06-13 |
2016-01-28 |
Incyte Corp |
Salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
|
DE102007034947B4
(de)
*
|
2007-07-26 |
2009-06-18 |
Siemens Ag |
Vorrichtung zum Entladen eines Stapels von auf ihren Schmalseiten stehenden flachen Gegenständen
|
US20090098594A1
(en)
*
|
2007-08-21 |
2009-04-16 |
Nodality, Inc. |
Methods for diagnosis prognosis and methods of treatment
|
WO2009046416A1
(en)
|
2007-10-05 |
2009-04-09 |
Targegen Inc. |
Anilinopyrimidines as jak kinase inhibitors
|
US20100310563A1
(en)
*
|
2007-11-30 |
2010-12-09 |
Bumm Thomas G P |
Methods for treating induced cellular proliferative disorders
|
US20100016218A1
(en)
*
|
2008-07-14 |
2010-01-21 |
Otonomy, Inc. |
Controlled-release apoptosis modulating compositions and methods for the treatment of otic disorders
|
AU2009279825A1
(en)
|
2008-08-05 |
2010-02-11 |
Targegen, Inc. |
Methods of treating thalassemia
|
EP2376500B1
(en)
|
2008-12-11 |
2015-02-25 |
Cti Biopharma Corp. |
11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene maleate salt
|
EP2229938B9
(en)
|
2009-03-13 |
2012-04-25 |
Sanovel Ilac Sanayi ve Ticaret A.S. |
Ezetimibe compositions
|
US20100297194A1
(en)
|
2009-04-30 |
2010-11-25 |
Nathaniel Catron |
Formulation for oral administration of apoptosis promoter
|
US20100278921A1
(en)
*
|
2009-04-30 |
2010-11-04 |
Fischer Cristina M |
Solid oral formulation of abt-263
|
CN102549003A
(zh)
|
2009-07-31 |
2012-07-04 |
巴斯夫欧洲公司 |
含咪唑基的膦硼烷化合物以及制备含咪唑基团膦硼烷化合物的方法
|
US20120157500A1
(en)
|
2009-08-24 |
2012-06-21 |
Weikang Tao |
Jak inhibition blocks rna interference associated toxicities
|
AU2010363329A1
(en)
|
2010-11-07 |
2013-05-09 |
Targegen, Inc. |
Compositions and methods for treating myelofibrosis
|
TW201316989A
(zh)
|
2011-07-21 |
2013-05-01 |
Sanofi Sa |
用於治療真性多血症及原發性血小板過多症之組合物及方法
|
WO2013059548A1
(en)
|
2011-10-19 |
2013-04-25 |
Sanofi |
Compositions and methods for treating cancer using jak2 inhibitor
|